A recent analysis of executive compensation packages at biotech and big pharma companies shed some light on the skyrocketing costs of drugs, and only one thing came to mind: greed. After all, the rising costs of these miraculous, sometimes lifesaving drugs impact us all and can influence everything from what foods we can afford to…
This article is only available to Business Times subscribers
Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
